Abstract:Abstract Background Gastric cancer (GC) is one of the most common and fatal cancers worldwide. Effective biomarkers to aid the early diagnosis of GC, as well as predict the course of disease, are urgently needed. Hence, we explored the role and function of cadherin-6 (CDH6) in the diagnosis and prognosis of gastric cancer. Methods The expression levels of CDH6 in cancerous and normal gastric tissue were analyzed using multiple public databases. Gene set enrichment analysis (GSEA) was performed using The Cancer Genome Atlas (TCGA) dataset. The diagnostic efficiency of CDH6 expression in GC patients was determined through receiver operating characteristic (ROC) curve analysis. The associations between clinical variables and CDH6 expression were evaluated statistically, and the prognostic factors for overall survival were analyzed by univariate and multivariate Cox regression. 44 GC tissue samples, 20 donor-matched adjacent normal tissue samples, and associated detailed clinical information, were collected from the Tianjin Medical University General Hospital. CDH6 expression levels were determined for further validation. Results CDH6 was upregulated in GC samples compared to normal gastric tissue. Furthermore, GSEA identified the tricarboxylic acid (TCA) cycle, extracellular matrix (ECM) receptor interaction, glyoxylate and dicarboxylate metabolism, oxidative phosphorylation, and the pentose phosphate pathway as differentially enriched in GC tissue samples. According to the area under the ROC curve (AUC) values (AUC = 0.829 in the TCGA and 0.966 in the GSE54129 dataset), CDH6 expression was associated with high diagnostic efficacy. Patients with high CDH6 levels in their GC tissues had a higher T number (according to the TNM classification) and a worse prognosis than those with low CDH6 expression. Univariate and multivariate Cox regression analysis showed that CDH6 was an independent risk factor for overall survival (univariate: HR = 1.305, P = 0.002, multivariate: HR = 1.481, P < 0.001). Conclusion CDH6 was upregulated in GC, and high CDH6 expression was indicative of a higher T number and a worse prognosis. Therefore, CDH6 represents a potentially independent molecular biomarker for the diagnostic and prognostic prediction of GC.

Increased Expression of Heat Shock Factor 1 (HSF1) is Associated with Poor Survival in Gastric Cancer Patients

Elevated Expression of Hypoxia Inducible Factor-1 Alpha is Correlates to Recurrence and Poor Outcome in Gastric Cancer

Clinical significance of heat shock protein 90α expression as a biomarker of prognosis in patients with gastric cancer

Meta-analysis of Immunohistochemical Expression of Hypoxia Inducible Factor-1Α As a Prognostic Role in Gastric Cancer.

High Expression of Heat Shock Protein Family D Member 1 Predicts Poor Prognosis of Esophageal Cancer

Prognostic Value of Hypoxia-Inducible Factor-1 Alpha and Prolyl 4-Hydroxylase Beta Polypeptide Overexpression in Gastric Cancer

Heat Shock Factor 1 in Relation to Tumor Angiogenesis and Disease Progression in Patients with Pancreatic Cancer

Expression of heat shock protein 27, 60 and 90 in gastric cancer and its clinical value

Expression of heat shock factor 1 and its relation with prognosis in breast cancer patients

Upregulation of Nuclear Heat Shock Factor 1 Contributes to Tumor Angiogenesis and Poor Survival in Patients with Non-Small Cell Lung Cancer

[Expression and Clinical Significance of Hypoxia-Inducible Factor-1Alpha in Gastric Cancer].

Elevated HOXA1 expression correlates with accelerated tumor cell proliferation and poor prognosis in gastric cancer partly via cyclin D1

High Expression of Regulator of G-protein Signalling 1 is Associated with the Poor Differentiation and Prognosis of Gastric Cancer.

High HSF4 expression is an independent indicator of poor overall survival and recurrence free survival in patients with primary colorectal cancer.

Heat shock factor 1 promotes invasion and metastasis of hepatocellular carcinoma in vitro and in vivo.

High expression of oncogene cadherin-6 correlates with tumor progression and a poor prognosis in gastric cancer

High expression level of T-box transcription factor 5 predicts unfavorable survival in stage I and II gastric adenocarcinoma.

Increased Expression of FOXQ1 is a Prognostic Marker for Patients with Gastric Cancer

Hypoxia-inducible Factor-1 Alpha Correlates with Tumor-Associated Macrophages Infiltration, Influences Survival of Gastric Cancer Patients.

Hif-1 Alpha Overexpression Correlates with Poor Overall Survival and Disease-Free Survival in Gastric Cancer Patients Post-Gastrectomy

HIF1A protein expression is correlated with clinical features in gastric cancer: an updated systematic review and meta-analysis